摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

噻吩-1-羧酸 | 96248-95-2

中文名称
噻吩-1-羧酸
中文别名
——
英文名称
thianthren-1-ylcarboxylic acid
英文别名
thianthrene-1-carboxylic acid;1-thianthrenecarboxylic acid;1-thianthrencarboxylic acid;Thianthren-1-carbonsaeure;Thianthren-carbonsaeure-(1)
噻吩-1-羧酸化学式
CAS
96248-95-2
化学式
C13H8O2S2
mdl
——
分子量
260.337
InChiKey
KBELHODUGYUEBC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    217-218 °C
  • 沸点:
    441.2±44.0 °C(Predicted)
  • 密度:
    1.466±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.7
  • 重原子数:
    17
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    87.9
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    噻吩-1-羧酸sodium ethanolate 作用下, 以 四氢呋喃乙醚 为溶剂, 反应 54.0h, 生成 1-(thianthren-1-yl)butane-1,3-dione
    参考文献:
    名称:
    Pyranone, Thiopyranone, and Pyridone Inhibitors of Phosphatidylinositol 3-Kinase Related Kinases. Structure−Activity Relationships for DNA-Dependent Protein Kinase Inhibition, and Identification of the First Potent and Selective Inhibitor of the Ataxia Telangiectasia Mutated Kinase
    摘要:
    Structure-activity relationships have been investigated for inhibition of DNA-dependent protein kinase (DNA-PK) and ATM kinase by a series of pyran-2-ones, pyran-4-ones, thiopyran-4-ones, and pyridin-4-ones. A wide range of IC50 values were observed for pyranones and thiopyranones substituted at the 6-position, with the 3- and 5-positions proving intolerant to substitution. Related pyran-2-ones, pyran-4-ones, and thiopyran-4-ones showed similar IC50 values against DNA-PK, whereas the pyridin-4-one system proved, in general, ineffective at inhibiting DNA-PK. Extended libraries exploring the 6-position of 2-morpholino-pyran-4-ones and 2-morpholino-thiopyrano-4-ones identified the first highly potent and selective ATM inhibitor 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one (151C; ATM; IC50 = 13 nM) and revealed constrained SARs for ATM inhibition compared with DNA-PK. One of the most potent DNA-PK inhibitors identified, 2-(4-methoxyphenyl)-6-(morpholin-4-yl)pyran-4-one (16; DNA-PK; IC50 = 220 nM) effectively sensitized HeLa cells to the topoisomerase II inhibitor etoposide in vitro.
    DOI:
    10.1021/jm061121y
  • 作为产物:
    描述:
    噻蒽正丁基锂乙醚 作用下, 生成 噻吩-1-羧酸
    参考文献:
    名称:
    Metalation of Thianthrene-5-dioxide by n-Butyllithium and by Phenyllithium and Cleavage of Thianthrene-5,5,10-trioxide by n-Butyllithium
    摘要:
    DOI:
    10.1021/ja01558a055
点击查看最新优质反应信息

文献信息

  • Potential antitumor agents. 54. Chromophore requirements for in vivo antitumor activity among the general class of linear tricyclic carboxamides
    作者:Brian D. Palmer、Gordon W. Rewcastle、Graham J. Atwell、Bruce C. Baguley、William A. Denny
    DOI:10.1021/jm00399a003
    日期:1988.4
    thioxanthenone, anthraquinone, pyridoquinazoline, dibenzodioxin, thianthrene, phenothiazine, phenoxazine, dibenzofuran, carbazole, and pyridoindole) of the general class of N-[2-(dimethylamino)ethyl] linear tricyclic carboxamides. Only the compounds containing coplanar chromophores intercalated DNA. There is an absolute requirement for an oxygen or aromatic nitrogen (possibly as hydrogen-bond acceptors) peri to
    报道了一般结构的许多不同实例(ac啶,吩嗪,a啶、,吨酮,噻吨酮蒽醌吡啶喹唑啉,二苯并二恶英,噻吨吩噻嗪吩恶嗪二苯并呋喃咔唑吡啶吲哚的结构-抗肿瘤活性关系。 N- [2-(二甲基基)乙基]线性三环羧酰胺。仅包含共面发色团的化合物插入DNA。绝对需要羧酰胺周围的氧或芳族氮(可能是氢键受体),以及用于生物活性的平面环几何形状。除了进一步描述这类化合物的药效基团的性质外,该工作还确定了二苯并[1,4]二恶英是一种具有体内抗肿瘤活性的新型DNA嵌入发色团。
  • ATM inhibitors
    申请人:Kudos Pharmaceuticals Ltd
    公开号:US20040002492A1
    公开(公告)日:2004-01-01
    The application concerns a compound of formula I: 1 wherein one of P and Q is O, and the other of P and Q is CH, where there is a double bond between whichever of Q and P is CH and the carbon atom bearing the R 3 group; Y is either O or S; R 1 and R 2 are independently hydrogen, an optionally substituted C 1-7 alkyl group, C 3-20 heterocyclyl group, or C 5-20 aryl group, or may together form an optionally substituted heterocyclic ring having from 4 to 8 ring atoms; R 3 is a phenyl or pyridyl group, attached by a first bridge group selected from —S—, —S(═O)—, —S(═O) 2 —, —O—, —NR N — and CR C1 R C2 — to an optionally substituted C 5-20 carboaryl group, the phenyl or pyridyl group and optionally substituted C 5-20 carboaryl group being optionally further linked by a second bridge group, so as to form an optionally substituted C 5-7 ring, the phenyl or pyridyl group being further optionally substituted.
    该应用涉及一种具有以下式I的化合物:其中P和Q中的一个是O,另一个是CH,Q和P中的CH之一之间存在双键,并且带有R3基团的碳原子;Y可以是O或S;R1和R2独立地是氢、可选择地取代的C1-7烷基、C3-20杂环基团或C5-20芳基,或者可以一起形成具有4至8个环原子的可选择地取代的杂环环;R3是苯基或吡啶基团,通过第一桥基团连接到一个可选择地取代的C5-20碳芳基团,该苯基或吡啶基团和可选择地取代的C5-20碳芳基团可以进一步通过第二桥基团连接,从而形成一个可选择地取代的C5-7环,苯基或吡啶基团可以进一步选择性地取代。
  • Synthesis of 1- and 2-substituted thianthrenes
    作者:James M. Lovell、John A. Joule
    DOI:10.1039/p19960002391
    日期:——
    Lithiation of thianthrene at C-1 allows the synthesis of various 1-substituted thianthrenes for example thianthren-1-ylboronic acid and 1-tributylstannylthianthrene, which undergo palladium-catalysed couplings with aryl halides. 2-Bromothianthrene provides an entry to 2-substituted thianthrenes via lithium–halogen exchange then reaction of 2-lithiothianthrene with electrophiles including formation of the 2-boronic acid and 2-tributylstannylthianthrene which were coupled to aryl halides.
    噻蒽 C-1 的化反应可以合成各种 1-取代的噻蒽,例如噻蒽-1-基硼酸和 1-三丁基锡噻蒽,它们与芳基卤化物发生催化偶联反应。通过-卤素交换,2-溴噻蒽进入 2-取代噻蒽,然后 2-噻蒽与亲电物反应,包括形成 2-硼酸和 2-三丁基锡噻蒽,并与芳基卤化物偶联。
  • Synthesis of 4,6-disubstituted thianthrenes; X-ray crystal structures of 4,6-diphenylthianthrene and 1-tetrathiafulvalenylnaphthalene
    作者:James M. Lovell、Roy L. Beddoes、John A. Joule
    DOI:10.1016/0040-4020(96)00145-7
    日期:1996.3
    Lithiation of thianthrene 5-oxide, then trapping with chlorotrimethylsilane gave 4-mono-, 4,6-di, 4b, and 4,6,9-tri-TMS derivatives. Reduction of oxide 4b to the thianthrene followed by reaction with bromine gave 4,6-dibromothianthrene which coupled smoothly with phenylboronic acid producing 4,6-diphenylthianthrene, 5c. The crystal structures of 5c and of 4-(1-naphthalenyl)-2-(1,3-dithiol-2-ylidene)-1
    氧化噻吩5-氧化物,然后用三甲基氯硅烷捕集,得到4-单-,4,6-di,4b和4,6,9-tri-TMS衍生物。将氧化物4b还原成噻吨,然后与反应,得到4,6-二噻吨,其与苯基硼酸平滑地偶联,产生4,6-二苯基噻吨5c。测定了5c和4-(1-基)-2-(1,3-二醇-2-亚烷基)-1,3-二醇的晶体结构。
  • [EN] PYRANONES USEFUL AS ATM INHIBITORS<br/>[FR] PYRANONES UTILES COMME INHIBITEURS DE L'ATM
    申请人:KUDOS PHARM LTD
    公开号:WO2003070726A1
    公开(公告)日:2003-08-28
    The application concerns a compound of formula I: (I) wherein one of P and Q is O, and the other of P and Q is H, where there is a double bond between whichever of Q and P is CH and the carbon atom bearing the R3 group;Y is either O or S;R1 and R2 are independently hydrogen, an optionally substituted C1-7 alkyl group, C3-20 heterocyclyl group, or C5-20 aryl group, or may together form an optionally substituted heterocyclic ring having from 4 to 8 ring atoms;R3 is a phenyl or pyridyl group, attached by a first bridge group selected from -S-, -S (=O)-, -S(=O)2-, -O-, -NRN- and CRC1RC2- to an optionally substituted C5-20 carboaryl group, the phenyl or pyridyl group and optionally substituted C5-20 carboaryl group being optionally further linked by a second bridge group, so as to form an optionally substituted C5-7 ring, the phenyl or pyridyl group being further optionally substituted.
    该应用涉及一种具有化学式I的化合物:(I)其中P和Q中的一个是O,另一个是H,在Q和P中的哪一个是CH和带有R3基团的碳原子之间存在双键;Y可以是O或S;R1和R2独立地是氢,可选的取代C1-7烷基,C3-20杂环基团或C5-20芳基团,或者可以共同形成具有4至8个环原子的可选取代杂环环;R3是连接到可选取代的C5-20碳基芳基基团的苯基或吡啶基团,该苯基或吡啶基团通过第一桥基团(选自-S-,-S(=O)-,-S(=O)2-,-O-,-NRN-和CRC1RC2-)连接,苯基或吡啶基团和可选取代的C5-20碳基芳基基团可以通过第二桥基团进一步连接,以形成可选取代的C5-7环,苯基或吡啶基团可以进一步取代。
查看更多

同类化合物

硫杂蒽,1,9-二(苯基硫代)-,10-氧化 硅烷,1,9-硫杂蒽二基二[三甲基- 甲硫芬 噻蒽-2-硼酸 噻蒽-1,9-二甲酸 噻蒽 5-氧化物 噻蒽 5,10-二氧化物 噻蒽 噻吩-1-羧酸 噻吩-1-硼酸 六氟磷酸1-氯-5-苯基-硫杂蒽-5-正离子 二甲基噻蒽 5-(三氟甲基)-5H-二硫杂蒽-5-鎓三氟甲磺酸盐 2-溴噻蒽 2-吗啉-4-基-6-噻蒽-1-基吡喃-4-酮 2,7-噻蒽二甲酸 2,7-二氟噻蒽 2,7-二乙酰基噻蒽 2,3,7,8-四甲基-1,4,6,9-噻蒽四酮 2,3,7,8-四氯噻蒽 1,4,6,9-噻蒽四酮 (7-硝基噻吩-2-基)硫氰酸盐 dimethyl-(3-phenothiaphosphin-10-yl-propyl)-amine 10-oxo-10H-10λ4-pheniodathiinium; bromide 2-Thianthrenylthioacetmorpholid benzo[1,3]dithiol-2-ylidene-thiazol-2-yl-amine 1,3,6,8-Tetranitro-9H-carbazole; compound with 10H-phenothiazine N-(8-Methanesulfonyl-dibenzo[1,4,5]thiadiazepin-2-yl)-acetamide dithieno[2,3-b;3',2'-e]thiopyran-4-one α-Bromoacetylthianthrene 3-(2-chlorophenothiazin-10-yl)-N,N-diethylpropan-1-amine;europium(3+);trinitrate 5-<(Cyanoacetyl)imino>5,5-dihydrothianthren 1-methoxy-thianthrene-5,5,10,10-tetraoxide 1,1'-dithianthrenyl ether tri-thianthren-2-yl-cyclotriboroxane 2-(2-Thianthrenyl)imidazo<1,2-a>pyridin 4-phenylselanylthianthrene 5-oxide 5-(4-hydroxy-3,5-di-fluorophenyl)thianthreniumyl perchlorate (Pyrrocolinyl-2)-2-thianthren perdeuteriothianthrene 5-(4-hydroxy-3-allylphenyl)thianthreniumyl perchlorate 1,9-dithiatrimethylene-bridged thianthrene-10-oxide thianthrenylidene t-butylamine thianthrene-2-carboxylic acid amide 2,7-bis-chloroacetyl-thianthrene thianthren-1-yloxy-acetic acid 5,5,10,10-tetraoxo-5λ6,10λ6-thianthrene-1-carboxylic acid dimethylbis(thianthren-1-yl)tin thianthren-1-yloxy-acetic acid ethyl ester